Connection

Carol Feghali-Bostwick to Fibrosis

Back to Details
This is a "connection" page, showing publications Carol Feghali-Bostwick has written about Fibrosis.
Carol Feghali-Bostwick
Connection Strength
4.489
Fibrosis
  1. E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects. JCI Insight. 2021 12 22; 6(24).
    View in: PubMed
    Score: 0.667
  2. Phenotypic Characterization of Transgenic Mice Expressing Human IGFBP-5. Int J Mol Sci. 2020 Dec 30; 22(1).
    View in: PubMed
    Score: 0.623
  3. Syndecan-2 is a novel target of insulin-like growth factor binding protein-3 and is over-expressed in fibrosis. PLoS One. 2012; 7(8):e43049.
    View in: PubMed
    Score: 0.348
  4. A peptide derived from endostatin ameliorates organ fibrosis. Sci Transl Med. 2012 May 30; 4(136):136ra71.
    View in: PubMed
    Score: 0.344
  5. Reduced Cathepsin L expression and secretion into the extracellular milieu contribute to lung fibrosis in systemic sclerosis. Rheumatology (Oxford). 2023 03 01; 62(3):1306-1316.
    View in: PubMed
    Score: 0.181
  6. First Characterization of the Transcriptome of Lung Fibroblasts of SSc Patients and Healthy Donors of African Ancestry. Int J Mol Sci. 2023 Feb 11; 24(4).
    View in: PubMed
    Score: 0.180
  7. The Molecular Mechanisms of Systemic Sclerosis-Associated Lung Fibrosis. Int J Mol Sci. 2023 Feb 03; 24(3).
    View in: PubMed
    Score: 0.180
  8. Elucidating the cellular mechanism for E2-induced dermal fibrosis. Arthritis Res Ther. 2021 02 27; 23(1):68.
    View in: PubMed
    Score: 0.158
  9. Prediction of severity and subtype of fibrosing disease using model informed by inflammation and extracellular matrix gene index. PLoS One. 2020; 15(10):e0240986.
    View in: PubMed
    Score: 0.154
  10. Excessive exosome release is the pathogenic pathway linking a lysosomal deficiency to generalized fibrosis. Sci Adv. 2019 07; 5(7):eaav3270.
    View in: PubMed
    Score: 0.141
  11. A Human Skin Model Recapitulates Systemic Sclerosis Dermal Fibrosis and Identifies COL22A1 as a TGF? Early Response Gene that Mediates Fibroblast to Myofibroblast Transition. Genes (Basel). 2019 01 22; 10(2).
    View in: PubMed
    Score: 0.136
  12. IGFBP-5 Promotes Fibrosis Independently of Its Translocation to the Nucleus and Its Interaction with Nucleolin and IGF. PLoS One. 2015; 10(6):e0130546.
    View in: PubMed
    Score: 0.106
  13. The membrane-associated adaptor protein DOK5 is upregulated in systemic sclerosis and associated with IGFBP-5-induced fibrosis. PLoS One. 2014; 9(2):e87754.
    View in: PubMed
    Score: 0.097
  14. Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis. Arthritis Res Ther. 2013 Jan 10; 15(1):R10.
    View in: PubMed
    Score: 0.090
  15. Role of endostatin in fibroproliferative disorders.-as a candidate for anti-fibrosis therapy-. Nihon Rinsho Meneki Gakkai Kaishi. 2013; 36(6):452-8.
    View in: PubMed
    Score: 0.090
  16. Antifibrotic effects of roscovitine in normal and scleroderma fibroblasts. PLoS One. 2012; 7(11):e48560.
    View in: PubMed
    Score: 0.089
  17. Early growth response transcription factors: key mediators of fibrosis and novel targets for anti-fibrotic therapy. Matrix Biol. 2011 May; 30(4):235-42.
    View in: PubMed
    Score: 0.079
  18. Decreased caveolin-1 levels contribute to fibrosis and deposition of extracellular IGFBP-5. J Cell Mol Med. 2011 Apr; 15(4):957-69.
    View in: PubMed
    Score: 0.079
  19. Role of insulin-like growth factor binding protein-3 in allergic airway remodeling. Am J Respir Crit Care Med. 2009 Oct 01; 180(7):611-7.
    View in: PubMed
    Score: 0.070
  20. The pro-fibrotic factor IGFBP-5 induces lung fibroblast and mononuclear cell migration. Am J Respir Cell Mol Biol. 2009 Aug; 41(2):179-88.
    View in: PubMed
    Score: 0.068
  21. Impairment of the antifibrotic effect of hepatocyte growth factor in lung fibroblasts from African Americans: possible role in systemic sclerosis. Arthritis Rheum. 2007 Jul; 56(7):2432-42.
    View in: PubMed
    Score: 0.061
  22. Insulin-like growth factor binding protein 5 induces skin fibrosis: A novel murine model for dermal fibrosis. Arthritis Rheum. 2006 Sep; 54(9):3001-10.
    View in: PubMed
    Score: 0.058
  23. Insulin-like growth factor binding proteins 3 and 5 are overexpressed in idiopathic pulmonary fibrosis and contribute to extracellular matrix deposition. Am J Pathol. 2005 Feb; 166(2):399-407.
    View in: PubMed
    Score: 0.052
  24. Vaccination-based immunotherapy to target profibrotic cells in liver and lung. Cell Stem Cell. 2022 10 06; 29(10):1459-1474.e9.
    View in: PubMed
    Score: 0.044
  25. Exercise as a multi-modal disease-modifying medicine in systemic sclerosis: An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS). Best Pract Res Clin Rheumatol. 2021 09; 35(3):101695.
    View in: PubMed
    Score: 0.040
  26. Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH. Ann Rheum Dis. 2020 04; 79(4):507-517.
    View in: PubMed
    Score: 0.037
  27. Characterization of human PDGFR-?-positive pericytes from IPF and non-IPF lungs. Am J Physiol Lung Cell Mol Physiol. 2018 12 01; 315(6):L991-L1002.
    View in: PubMed
    Score: 0.033
  28. Pro-fibrotic phenotype of human skin fibroblasts induced by periostin via modulating TGF-? signaling. J Dermatol Sci. 2018 May; 90(2):199-208.
    View in: PubMed
    Score: 0.032
  29. Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis. Arthritis Res Ther. 2017 06 17; 19(1):144.
    View in: PubMed
    Score: 0.030
  30. Review: Frontiers of Antifibrotic Therapy in Systemic Sclerosis. Arthritis Rheumatol. 2017 02; 69(2):257-267.
    View in: PubMed
    Score: 0.030
  31. Tenascin-C drives persistence of organ fibrosis. Nat Commun. 2016 06 03; 7:11703.
    View in: PubMed
    Score: 0.028
  32. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis. Arthritis Rheumatol. 2016 05; 68(5):1251-61.
    View in: PubMed
    Score: 0.028
  33. Interleukin-13-producing CD8+ T cells mediate dermal fibrosis in patients with systemic sclerosis. Arthritis Rheum. 2013 Jan; 65(1):236-46.
    View in: PubMed
    Score: 0.022
  34. Toll-like receptor 4 signaling augments transforming growth factor-? responses: a novel mechanism for maintaining and amplifying fibrosis in scleroderma. Am J Pathol. 2013 Jan; 182(1):192-205.
    View in: PubMed
    Score: 0.022
  35. The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis Rheum. 2011 Nov; 63(11):3563-74.
    View in: PubMed
    Score: 0.021
  36. The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-? that is up-regulated in systemic sclerosis and mediates profibrotic responses. Am J Pathol. 2011 May; 178(5):2077-90.
    View in: PubMed
    Score: 0.020
  37. PPAR? downregulation by TGF? in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis. PLoS One. 2010 Nov 02; 5(11):e13778.
    View in: PubMed
    Score: 0.019
  38. Smad-independent transforming growth factor-beta regulation of early growth response-1 and sustained expression in fibrosis: implications for scleroderma. Am J Pathol. 2008 Oct; 173(4):1085-99.
    View in: PubMed
    Score: 0.017
  39. Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis. J Exp Med. 2006 Dec 25; 203(13):2895-906.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.